Vail Scientific
Vail Scientific has developed a non-invasive, breathalyzer, rapid sepsis detection technology designed for point-of-care and early intervention, such as Triage, alongside other vital signs and clinical assessments. The technology may be utilized in many diverse settings including hospitals, urgent care, nursing homes and even mobile military field hospitals. Vail's portable proprietary analyzer weighs less than 9 lbs. The company leverages exhaled nitric oxide (Nobel Prize in Medicine winning molecule) measurement for enhanced sensitivity and speed in sepsis screening, aiming to reduce mortality rates and improve patient outcomes. Since 2019, Vail Scientific has focused on clinical research, device innovation, and advancing toward commercialization/regulatory clearance.
Industries
Nr. of Employees
small (1-50)
Vail Scientific
7800 Metro Parkway Suite 105 Bloomington, MN 55425
Vail Scientific is currently seeking investment
Vail Scientific is seeking a series-a investment in the range of 5m-20m
Patents
Apparatus and method for the determination of endothelial dysfunction and sepsis risk using nitric oxide concentrations in exhaled breath
2026-02-03 • US-12539073-B1
View Details
Apparatus and method for the determination of endothelial dysfunction and sepsis risk using nitric oxide concentrations in exhaled breath
2026-02-03 • US-12539073-B1
View DetailsProducts
Non-invasive breath-based sepsis screening device
Portable, handheld diagnostic device measuring exhaled nitric oxide for rapid, point-of-care detection of sepsis in emergency and triage settings alongside other vital signs and clinical assessments. Vail's device incorporates a proprietary flow control which is critical for patients ease of use.
Non-invasive breath-based sepsis screening device
Portable, handheld diagnostic device measuring exhaled nitric oxide for rapid, point-of-care detection of sepsis in emergency and triage settings alongside other vital signs and clinical assessments. Vail's device incorporates a proprietary flow control which is critical for patients ease of use.
Expertise Areas
- Sepsis diagnostics
- Point-of-care medical devices
- Biomarker-based screening
- Emergency medicine clinical research
Key Technologies
- Exhaled nitric oxide measurement
- Portable breath analysis
- Algorithmic clinical scoring
- Handheld diagnostic devices
Key People
Chief Executive Officer, Chairman of Board
Chief Technology Officer, Board Member
Chief Scientific Officer
Chief Financial Officer
Board Member
Board Member
Chief Executive Officer, Chairman of Board
Chief Technology Officer, Board Member
Chief Scientific Officer
Chief Financial Officer
Board Member
Board Member
News & Updates
Design News article highlighting development of portable breath analyzer for sepsis risk screening.
Announcement of strategic collaboration for redesign and manufacture of a portable sepsis detection device.
Medical Design & Outsourcing features Vail Scientific’s updated point-of-care device for sepsis detection.
Publication of trial results: evaluation of diagnostic accuracy of exhaled nitric oxide for infection and sepsis.
Secured a $2.0 million investment from Exit 156 to accelerate development and commercialization of rapid sepsis detection technology.
Completed an oversubscribed funding round in August 2021 to support proof-of-concept studies and device development.
Design News article highlighting development of portable breath analyzer for sepsis risk screening.
Announcement of strategic collaboration for redesign and manufacture of a portable sepsis detection device.
Medical Design & Outsourcing features Vail Scientific’s updated point-of-care device for sepsis detection.
Publication of trial results: evaluation of diagnostic accuracy of exhaled nitric oxide for infection and sepsis.
Secured a $2.0 million investment from Exit 156 to accelerate development and commercialization of rapid sepsis detection technology.
Completed an oversubscribed funding round in August 2021 to support proof-of-concept studies and device development.